It’s a science article on slow lungs.

Chronic obstructive Pulmonary Disease, COPD is a common chronic respiratory disease characterized by persistent air flow restrictions and corresponding respiratory symptoms. Not only does the COPD seriously affect the quality of life of patients, it is also one of the leading causes of death worldwide. The present paper will provide a comprehensive analysis of the COPD in terms of causes, symptoms, diagnosis, prevention and treatment, with a view to raising the level of awareness and management of the disease. The main cause of the COPD is long-term smoking. Research shows that smokers are more than four times more at risk from COPD than non-smokers (Rennard & Vestbo, 2020). The long-term inhalation of harmful particulates and gases in the occupational environment, such as mine dust, chemical materials, etc., is also an important risk factor (Viegi et al., 2007) due mainly to smoking, occupational dust and chemical inhalation, air pollution, respiratory infections, etc. Internal factors include genetic factors, increased aerobic reaction and individual lung development or poor growth. Typical symptoms of the COPD include chronic cough, cough and sexual respiratory difficulties. Early symptoms may be minor, but as the condition evolves, the patient will gradually feel limited in his or her day-to-day activities and, in serious cases, will not even be able to complete a simple housework or walk. The diagnosis of COPD usually requires a combination of clinical assessment, lung function testing and video-testing. Pneumonia is slow, has a long pathology and early is free of self-inception symptoms. The diagnosis of chronic cough, cough, short-temporal, breathing difficulties, asthma and chest suffocation can be associated with the progression of the disease. The diagnosis of COPD usually requires a combination of clinical assessment, lung function testing and video-testing. The FEV1/FVC margin of less than 0.7 in the lung function test is an important indicator for the diagnosis of the COPD. Breast X-ray and CT scans help to remove other lung diseases and to assess the severity of the disease The key to preventing COPD is to avoid known risk factors. For smokers, cessation is the most effective preventive measure. Public health policies should strengthen tobacco control and reduce public exposure to tobacco products. The principles of treatment for slow lung resistance include prevention and comprehensive treatment, individualization of treatment measures, etc. The aim is to reduce symptoms, prevent the development of conditions and improve the quality of life. Drugs: bronchial extension agents: including long-acting β2 receptor agonists (LABA) and long-activated anticholines (LAMA), Sametro, Formotro, etc. In addition, sugar cortex hormones, diesterase-4 inhibitors, etc., can be used for treatment of slow lungs. Non-pharmaceuticals: including home oxygen therapy, respiratory exercise, physiotherapy, etc. – Support for cessation of smoking: professional counselling and support to help patients to quit smoking completely. Prevention: The key to prevention of slow lung resistance is cessation of smoking and avoidance of inhalation of harmful gases Psychological support: providing psychological counselling and family support to help patients cope with the psychological stress caused by the disease The management of slow lung resistance requires a multifaceted and integrated strategy that includes cooperation among doctors, nurses, therapists, nutritionists and psychologists, as well as patients themselves and their families. In recent years, significant progress has been made in the study of slow lung resistance. For example, studies have shown that P63+ LPC cell transplants show much more potential for treatment of slow-retarded lungs than traditional treatments. In addition, a number of new drugs and treatments are being developed and applied, offering more hope for patients with slow-down lung. Conclusion: Slow lung resistance is a common and serious respiratory disease, but patients can be effectively controlled through standardized treatment, regular follow-up and good self-management. Understanding the causes of slow lung resistance, clinical performance, diagnostic methods and treatment programmes are important for improving the quality of life of patients and reducing mortality. By taking effective preventive measures, timely diagnosis and reasonable treatment, the quality of life of patients can be significantly improved. Improved self-management of patients and development of more accurate individualized medical programmes. It is hoped that this paper will help readers to better understand and manage the COPD and bring more hope and help to patients. References “Barnes, P. J. (2012). Chronic obstractive democracy-adjusset. New England Journal of Medicine, 367 (8), 755-765. Burney, P. G., Patel, J., Newson, R.T., Naghavi, M., Shahraz, S., & Jarvholm, B. (2010). Global and regional disease-adjusted life years for 291 diseases and injuries in 21 countries, 1990-2010: a systatic analysis for the Global Burden of Dise Disease 2010. The Lancet, 380 (9859), 2197-2223.